LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.

    Song, Chiman / Bae, Yeonju / Jun, JinJoo / Lee, Hyomin / Kim, Nam Doo / Lee, Kyung-Bok / Hur, Wooyoung / Park, Jae-Yong / Sim, Taebo

    Biochimica et biophysica acta. General subjects

    2017  Volume 1861, Issue 4, Page(s) 947–957

    Abstract: ... inhibitor and a potent inhibitor of breast cancer cell migration.: General significance: TG100-115 ... but significantly decreases cell migration and invasion. Moreover, TG100-115 inhibits TRPM7 kinase regulated ... this method, we discovered a new and potent TRPM7 kinase inhibitor, TG100-115. TG100-115 inhibited TRPM7 ...

    Abstract Background: Transient receptor potential melastatin 7 (TRPM7) regulates breast cancer cell proliferation, migration, invasion and metastasis in its ion channel- and kinase domain-dependent manner. The pharmacological effects of TRPM7 ion channel inhibitors on breast cancer cells have been studied, but little is known about the effects of TRPM7 kinase domain inhibitors due to lack of potent TRPM7 kinase inhibitors.
    Methods: Screening was performed by using TRPM7 kinase assay. Effects of TG100-115 on breast cancer cell proliferation, migration, invasion, myosin IIA phosphorylation, and TRPM7 ion channel activity were assessed by using MTT, wound healing, transwell assay, Western blotting, and patch clamping, respectively.
    Results: We found that CREB peptide is a potent substrate for the TR-FRET based TRPM7 kinase assay. Using this method, we discovered a new and potent TRPM7 kinase inhibitor, TG100-115. TG100-115 inhibited TRPM7 kinase activity in an ATP competitive fashion with over 70-fold stronger activity than that of rottlerin, known as a TRPM7 kinase inhibitor. TG100-115 has little effect on proliferation of MDA-MB-231 cells, but significantly decreases cell migration and invasion. Moreover, TG100-115 inhibits TRPM7 kinase regulated phosphorylation of the myosin IIA heavy chain and phosphorylation of focal adhesion kinase. TG100-115 also suppressed TRPM7 ion channel activity.
    Conclusions: TG100-115 can be used as a potent TRPM7 kinase inhibitor and a potent inhibitor of breast cancer cell migration.
    General significance: TG100-115 could be a useful tool for studying the pharmacological effects of TRPM7 kinase activity aimed at providing insight into new therapeutic approaches to the treatment of breast cancer.
    MeSH term(s) Adenosine Triphosphate/metabolism ; Breast Neoplasms/drug therapy ; Breast Neoplasms/metabolism ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cyclic AMP Response Element-Binding Protein/metabolism ; Female ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Humans ; Neoplasm Invasiveness/pathology ; Nonmuscle Myosin Type IIA/metabolism ; Phenols/pharmacology ; Phosphorylation/drug effects ; Protein Kinase Inhibitors/pharmacology ; Protein-Serine-Threonine Kinases/antagonists & inhibitors ; Pteridines/pharmacology ; TRPM Cation Channels/antagonists & inhibitors
    Chemical Substances 3-(2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl)phenol ; Cyclic AMP Response Element-Binding Protein ; Phenols ; Protein Kinase Inhibitors ; Pteridines ; TRPM Cation Channels ; Adenosine Triphosphate (8L70Q75FXE) ; Focal Adhesion Protein-Tyrosine Kinases (EC 2.7.10.2) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; TRPM7 protein, human (EC 2.7.11.1) ; Nonmuscle Myosin Type IIA (EC 3.6.1.-)
    Language English
    Publishing date 2017-02-01
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0304-4165 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0304-4165 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbagen.2017.01.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion

    Song, Chiman / Hyomin Lee / Jae-Yong Park / JinJoo Jun / Kyung-Bok Lee / Nam Doo Kim / Taebo Sim / Wooyoung Hur / Yeonju Bae

    Biochimica et biophysica acta. 2017 Apr., v. 1861, no. 4

    2017  

    Abstract: ... ion channel activity.TG100-115 can be used as a potent TRPM7 kinase inhibitor and a potent inhibitor of breast ... decreases cell migration and invasion. Moreover, TG100-115 inhibits TRPM7 kinase regulated phosphorylation ... we discovered a new and potent TRPM7 kinase inhibitor, TG100-115. TG100-115 inhibited TRPM7 kinase activity ...

    Abstract Transient receptor potential melastatin 7 (TRPM7) regulates breast cancer cell proliferation, migration, invasion and metastasis in its ion channel- and kinase domain-dependent manner. The pharmacological effects of TRPM7 ion channel inhibitors on breast cancer cells have been studied, but little is known about the effects of TRPM7 kinase domain inhibitors due to lack of potent TRPM7 kinase inhibitors.Screening was performed by using TRPM7 kinase assay. Effects of TG100-115 on breast cancer cell proliferation, migration, invasion, myosin IIA phosphorylation, and TRPM7 ion channel activity were assessed by using MTT, wound healing, transwell assay, Western blotting, and patch clamping, respectively.We found that CREB peptide is a potent substrate for the TR-FRET based TRPM7 kinase assay. Using this method, we discovered a new and potent TRPM7 kinase inhibitor, TG100-115. TG100-115 inhibited TRPM7 kinase activity in an ATP competitive fashion with over 70-fold stronger activity than that of rottlerin, known as a TRPM7 kinase inhibitor. TG100-115 has little effect on proliferation of MDA-MB-231 cells, but significantly decreases cell migration and invasion. Moreover, TG100-115 inhibits TRPM7 kinase regulated phosphorylation of the myosin IIA heavy chain and phosphorylation of focal adhesion kinase. TG100-115 also suppressed TRPM7 ion channel activity.TG100-115 can be used as a potent TRPM7 kinase inhibitor and a potent inhibitor of breast cancer cell migration.TG100-115 could be a useful tool for studying the pharmacological effects of TRPM7 kinase activity aimed at providing insight into new therapeutic approaches to the treatment of breast cancer.
    Keywords adenosine triphosphate ; breast neoplasms ; cell movement ; cell proliferation ; ion channels ; metastasis ; myosin ; neoplasm cells ; non-specific protein-tyrosine kinase ; phosphorylation ; tissue repair ; Western blotting
    Language English
    Dates of publication 2017-04
    Size p. 947-957.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 840755-1
    ISSN 0304-4165
    ISSN 0304-4165
    DOI 10.1016/j.bbagen.2017.01.034
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top